Valuation: BioHarvest Sciences Inc.

Market Cap 61.2M 53.49M 49.35M 45.49M 85.75M 5.89B 87.65M 590M 232M 2.89B 230M 225M 9.94B P/E 2026 *
-6.63x
P/E 2027 * -16.4x
Enterprise Value 61.2M 53.49M 49.35M 45.49M 85.75M 5.89B 87.65M 590M 232M 2.89B 230M 225M 9.94B EV / Sales 2026 *
1.43x
EV / Sales 2027 * 1.04x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 2026-04-28
Director of Finance/CFO - 2024-10-27
Chief Operating Officer 65 2023-04-18
Director TitleAgeSince
Chairman 68 2018-09-26
Director/Board Member 67 2018-09-26
Director/Board Member 84 2019-02-06
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 61.2M
-1.32%+5.33%-8.55%-5.18% 13.54B
-3.30%+9.97%-27.67%-49.81% 5.27B
-2.47%+7.14%+0.62%-4.09% 4.72B
-5.06%+6.38%+8.55%-32.43% 4.07B
-2.65%+2.32%+4.01%-8.76% 3.75B
0.00%+9.56%-4.89%-3.35% 3.57B
-3.45%+9.23%-5.06%+7.03% 3.39B
-3.77%+0.45%-13.12%-22.74% 2.42B
-2.82%+3.13%-1.88%+49.73% 1.86B
Average -1.88%+2.57%-5.33%-7.73% 4.73B
Weighted average by Cap. -2.42%+3.08%-6.55%-10.97%

Financials

2026 *2027 *
Net sales 42.89M 37.48M 34.59M 31.88M 60.09M 4.13B 61.42M 413M 163M 2.02B 161M 158M 6.96B 58.96M 51.52M 47.54M 43.82M 82.6M 5.68B 84.43M 568M 224M 2.78B 221M 217M 9.57B
Net income -9.27M -8.1M -7.47M -6.89M -12.98M -892M -13.27M -89.31M -35.13M -437M -34.8M -34.03M -1.5B -3.77M -3.3M -3.04M -2.8M -5.29M -363M -5.4M -36.37M -14.3M -178M -14.17M -13.86M -613M
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.700USD
Average target price
12.75USD
Spread / Average Target
+372.22%

Quarterly revenue - Rate of surprise